These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 268780)

  • 1. Non-invasive study of the metabolism-to-blood flow relationship in Parkinson's disease.
    Lenzi GL; Jones T; Reid J; Moss S
    Acta Neurol Scand Suppl; 1977; 64():184-5. PubMed ID: 268780
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional impairment of cerebral oxidative metabolism in Parkinson's disease.
    Lenzi GL; Jones T; Reid JL; Moss S
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):59-62. PubMed ID: 762585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood flow and oxygen metabolism measurement with positron emission tomography in Parkinson's disease.
    Leenders KL; Wolfson L; Jones T
    Monogr Neural Sci; 1984; 11():180-6. PubMed ID: 6610825
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging techniques in Parkinson's disease.
    Martin WR
    Mov Disord; 1989; 4 Suppl 1():S63-9. PubMed ID: 2566914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Regional cerebral blood flow in the aging human brain and in Alzheimer's dementia and Parkinson's disease].
    Melamed E
    Harefuah; 1982 Nov; 103(10):234-6. PubMed ID: 7182319
    [No Abstract]   [Full Text] [Related]  

  • 6. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral oxygen metabolism in patients with early Parkinson's disease.
    Borghammer P; Cumming P; Østergaard K; Gjedde A; Rodell A; Bailey CJ; Vafaee MS
    J Neurol Sci; 2012 Feb; 313(1-2):123-8. PubMed ID: 21975016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation.
    Vafaee MS; ØStergaard K; Sunde N; Gjedde A; Dupont E; Cumming P
    Neuroimage; 2004 Jun; 22(2):966-74. PubMed ID: 15193628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow studied by Xenon-133 inhalation technique in parkinsonism: loss of hyperfrontal pattern.
    Bès A; Güell A; Fabre N; Dupui P; Victor G; Géraud G
    J Cereb Blood Flow Metab; 1983 Mar; 3(1):33-7. PubMed ID: 6822615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognitive function and regional cerebral blood flow in patients with Parkinson's disease].
    Tachibana H; Kawabata K
    Rinsho Shinkeigaku; 1992 Aug; 32(8):893-4. PubMed ID: 1490320
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral blood flow activation studies in Parkinson's disease.
    Brooks DJ
    Adv Neurol; 2001; 86():225-35. PubMed ID: 11553981
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased medial temporal blood flow in Parkinson's disease with pathological hypersexuality.
    Kataoka H; Shinkai T; Inoue M; Satoshi U
    Mov Disord; 2009 Feb; 24(3):471-3. PubMed ID: 19021228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral hemodynamics and clinical pharmacology in Parkinson disease].
    Marc-Vergnes JP; Celsis P; Montastruc JL; Demonet JF; Agniel A; Rascol O; Viallard G; Doyon B; Rascol A
    Therapie; 1988; 43(2):83-8. PubMed ID: 3406932
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of bromocriptine on cerebral blood flow in Parkinson's disease].
    Celsis P; Rascol O; Demonet JF; Agniel A; Montastruc JL; Marc-Vergnes JP; Rascol A
    Rev Neurol (Paris); 1988; 144(5):367-71. PubMed ID: 3420354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy.
    Scigliano G; Musicco M; Soliveri P; Girotti F; Giovannini P; Fetoni V; Caraceni T
    Adv Neurol; 1996; 69():305-9. PubMed ID: 8615143
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of cerebral atrophy and regional cerebral blood flow in patients with Parkinson's disease].
    Kitamura S
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):233-42. PubMed ID: 6863489
    [No Abstract]   [Full Text] [Related]  

  • 17. PET modifications after surgery for Parkinson's disease.
    Leenders KL
    Adv Neurol; 1997; 74():271-9. PubMed ID: 9348420
    [No Abstract]   [Full Text] [Related]  

  • 18. The cognitive neuropsychology of Parkinson's disease: a functional neuroimaging perspective.
    Owen AM; Doyon J
    Adv Neurol; 1999; 80():49-56. PubMed ID: 10410702
    [No Abstract]   [Full Text] [Related]  

  • 19. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
    Broussolle E; Cinotti L; Pollak P; Landais P; Le Bars D; Galy G; Lavenne F; Khalfallah Y; Chazot G; Mauguière F
    Mov Disord; 1993 Oct; 8(4):459-62. PubMed ID: 8232355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cerebral vasomotor reactivity in Parkinson's disease: is there any association with orthostatic hypotension?
    Zamani B; Mehrabani M; Fereshtehnejad SM; Rohani M
    Clin Neurol Neurosurg; 2011 Jun; 113(5):368-72. PubMed ID: 21247685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.